Close

content

Citius Pharma Announces Addition of South America to World License

Citius Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced that it has recently concluded...

Aptar Pharma Preservative-Free Multidose Dispenser Chosen For The First Time For A Prescription Dry Eye Product In The Us With Restasis Multidose

Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is available for patients in the U.S. prescription market for the first time with Allergan’s...

Selecting a dosage form for drug delivery to the lungs

Recipharm is frequently asked to help its clients select and develop an appropriate dosage form for their inhalation product development programs.When choosing between metered dose inhaler...

Recipharm partners with Sato to manufacture product for Japanese market

Recipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co. for the commercial manufacture and...

X-Chem Announces Strategic Collaboration with Astellas Pharma Across Multiple Therapeutic Areas

X-Chem, Inc. , a privately held biotechnology company applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, announced the...

Lilly’s Taltz Receives U.S. FDA Approval For The Treatment Of Moderate-To-Severe Plaque Psoriasis

Eli Lilly and Company announced today that the U.S. FDA has approved Taltz® injection 80 mg/mL for the treatment of moderate-to-severe plaque psoriasis in...

Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia

Selvita , a clinical stage drug discovery and development company focused on innovative medicines for patients with blood cancers, announced that the first patient...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read